Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2002
12/03/2002US6489144 Culturing cells that overproduce double-stranded-rna-dependent kinase and treatment with inducer
12/03/2002US6489141 Codon replacement for higher translational efficiency
12/03/2002US6489137 For use in cancer diagnostics; detection of the loss and or alteration of wild-type hubub1 genes in tumor tissues
12/03/2002US6489135 Evaluating health, implantability, and likelihood of pregnancy developing to term; reducing frequency of multiple births
12/03/2002US6489134 Kinesin motor modulators derived from the marine sponge Adocia
12/03/2002US6489133 Reflectance reading; porous matrix impregnated with reagent;measuring glucose in blood
12/03/2002US6489130 Death associated kinase containing ankyrin repeats (DAKAR)
12/03/2002US6489122 Chlamydia pneumoniae antigenic polypeptides, which comprise polypeptide a containing a sequence of at least 5 consecutive amino acids in the polypeptide of seq id no: 1, dnas encoding the antigenic polypeptides, or dnas complementary thereto;
12/03/2002US6489116 Sensitive, multiplexed diagnostic assays for protein analysis
12/03/2002US6489115 Genetic assays for trinucleotide repeat mutations in eukaryotic cells
12/03/2002US6489114 Process for labeling a ribonucleic acid, and labeled RNA fragments which are obtained thereby
12/03/2002US6489112 Preparing nanoscale reactions using nucleic acids are presented. nucleic acids are captured saturably, yet reversibly, on the internal surface of the reaction chamber, typically a capillary. excess nucleic acid is removed and the
12/03/2002US6489111 Apparatus and methods for immobilized DNA library preparation and gene amplification
12/03/2002US6489110 Amplifying a target containing mrna coding for the elongation factor ef-tu, determining the presence and/or amount of said mrna, and assessing mycobacterial viability based on the determination of the presence and/or amount of said mrna.
12/03/2002US6489109 Transcription-based gene mapping
12/03/2002US6489107 Method for identifying Escherichia coli strain DSM 6601
12/03/2002US6489106 Control of the expression of anchored genes using micron scale heaters
12/03/2002US6489105 Screening method for determining individuals at risk of developing diseases associated with different polymorphic forms of wildtype P53
12/03/2002US6489104 Screening for a dna encoding a protein that regulates the human p27.sup.kip1 promoter activity of a promoter dna, said promoter dna comprising at least a substantial portion of a fragment extending from nucleotide 2795 to nucleotide 3133 of
12/03/2002US6489103 In vitro sorting method
12/03/2002US6489102 Made using a reversible protecting group to reversibly modify omega-functionalized alkanethiols self-assembled on metal substrates, and immobilizing cells or biomolecules; use in surface plasmon resonance (spr) imaging
12/03/2002US6489099 Detection of DNA damaging agents
12/03/2002US6489098 Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
12/03/2002US6489097 Method for the detection of telomerase activity
12/03/2002US6489096 Systems and methods for enhanced quantitative analysis of hybridization intensity measurements obtained from oligonucleotide probes and other probes exposed to target samples are provided by virtue of the present invention. one
12/03/2002US6489095 Detecting preferential physical and hereditary genetic disorders; obtain sample, extract mitochondrial nucleotide sequences, compare to control, detect adjustment in seqences, evaluate for physical or genetic disorder
12/03/2002US6489094 Automatic
12/03/2002US6488935 Dna coding for a peptide of a papilloma virus major capsid protein and a papilloma virus genome, respectively
12/03/2002US6488828 Recloseable biosensor
12/03/2002CA2254853C Compositions and methods for screening antimicrobials
12/03/2002CA2042293C Reverse sample genome probing of sulphate-reducing bacteria
11/2002
11/30/2002CA2388268A1 Methods of determining polypeptide structure and function
11/30/2002CA2387406A1 Protein kinase peptide substrate determination using peptide libraries
11/30/2002CA2386755A1 Fluorescent group-containing carbodiimide compound and process for producing the compound
11/30/2002CA2384352A1 Novel polynucleotides from streptomyces avermitilis
11/29/2002WO2001092476A2 In vitro tissue test system
11/29/2002CA2410946A1 In vitro tissue test system
11/28/2002WO2002095416A2 Method for identifying micro-organisms using mass spectrometry
11/28/2002WO2002095413A2 Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia
11/28/2002WO2002095410A1 Adherent entities and uses therefor
11/28/2002WO2002095402A2 Individualization of therapy with hyperlipidemia agents
11/28/2002WO2002095399A2 Method for certifying chondrocytes for use in cartilage regeneration
11/28/2002WO2002095385A1 Biosensor
11/28/2002WO2002095375A1 Semen analysis
11/28/2002WO2002095363A2 Methods for attenuation of virulence in bacteria
11/28/2002WO2002095075A1 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
11/28/2002WO2002095074A1 Foot and mouth disease virus diagnostic and methods
11/28/2002WO2002095071A2 Means and methods for identifying genes and proteins involved in the prevention and/or repair of a replication error
11/28/2002WO2002095070A2 Polynucleotide sequencing method
11/28/2002WO2002095069A2 Methods
11/28/2002WO2002095068A2 Engineered secreted alkaline phosphatase (seap) reporter genes and polypeptides
11/28/2002WO2002095067A2 INTERFERON α-14 POLYMORPHISM
11/28/2002WO2002095066A2 Detecting microorganisms of the yersinia pestis/yersinia pseudotuberculosis species
11/28/2002WO2002095065A2 G-protein coupled receptor arrays
11/28/2002WO2002095064A1 Transporter arrays and methods and kits for producing and using the arrays
11/28/2002WO2002095063A1 Pyruvate-kinase as a novel target molecule
11/28/2002WO2002095061A1 Methods of screening test substances for treating or preventing diseases involving an oxidative stress
11/28/2002WO2002095059A2 Selection of target sites for antisense attack of rna
11/28/2002WO2002095058A2 Emission ratiometric indicators of phosphorylation
11/28/2002WO2002095057A2 Pairs of nucleic acid probes with interactive signaling moieties and nucleic acid probes with enhanced hybridization efficiency and specificity
11/28/2002WO2002095055A2 Compositions and methods for use in isolation of nucleic acid molecules
11/28/2002WO2002095052A2 Pna probes, probe sets, methods and kits pertaining to the detection of candida
11/28/2002WO2002095051A2 Mage-a3 peptides presented by hla class ii molecules
11/28/2002WO2002095050A2 Trinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment
11/28/2002WO2002095039A1 Protease deficient caulobacter host cells
11/28/2002WO2002095036A2 A novel intein and uses thereof
11/28/2002WO2002095034A2 A retinoic acid metabolizing cytochrome p450
11/28/2002WO2002095028A1 Polynucleotide probe and primer for detecting beer-clouding lactic acid bacteria and method of detecting beer-clouding lactic acid bacteria
11/28/2002WO2002095025A1 Novel smg-1
11/28/2002WO2002095017A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof
11/28/2002WO2002095003A2 Phytases, nucleic acids encoding them and methods for making and using them
11/28/2002WO2002095000A2 Molecular toxicology modeling
11/28/2002WO2002094997A2 Transcriptional regulation of target genes
11/28/2002WO2002094995A2 Methods and compositions using genetic package display
11/28/2002WO2002094990A2 Receptors and membrane-associated proteins
11/28/2002WO2002094985A2 Beta-secretase substrates and uses thereof
11/28/2002WO2002094982A2 Increasing bioavailability of carotenoids
11/28/2002WO2002094976A2 Identification of antimicrobial agents
11/28/2002WO2002094949A2 Detection method for identifying hydrolases
11/28/2002WO2002094878A1 Hevein-binding monoclonal antibodies
11/28/2002WO2002094874A2 Internalisation of virus into cells
11/28/2002WO2002094865A1 Nonhuman pregnane x receptor sequences for use in comparative pharmacology
11/28/2002WO2002094864A2 Human cdnas and proteins and uses thereof
11/28/2002WO2002094863A2 INTERFERON-α INDUCED GENE
11/28/2002WO2002094862A2 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
11/28/2002WO2002094861A2 Genes and proteins involved in the biosynthesis of enediyne ring structures
11/28/2002WO2002094850A2 Haplotypes of the gnrh2 gene
11/28/2002WO2002094780A2 Kinases and phosphatases
11/28/2002WO2002094778A2 Peptide conjugates and fluorescence detection methods for intracellular caspase assay
11/28/2002WO2002094777A2 Methods of detecting protein arginine methyltransferase, and uses related thereto
11/28/2002WO2002094314A1 Tsg101 as inhibitor of hiv production
11/28/2002WO2002094248A2 Composition and use of substances for stabilising amino acids containing sulphur and/or for inhibiting the continuous formation of amino acids containing sulphur in a blood sample
11/28/2002WO2002094203A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002WO2002094195A2 Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents
11/28/2002WO2002094194A2 Compositions and methods for inhibiting metastasis
11/28/2002WO2002094193A1 Methods for inhibiting angiogenesis
11/28/2002WO2002094185A2 Conjugates and compositions for cellular delivery
11/28/2002WO2002094084A2 Bmpr1a involvement in juvenile polyposis
11/28/2002WO2002083712A8 Transporters and ion channels
11/28/2002WO2002077245A9 Assay for drug-induced recoding